MTM
1. Which of the following is a benefit of standardizing the patient care process?
a. Facilitating development of supporting infrastructure, such as electronic health
records (EHR).
b. Minimizing the amount of clinical training required for pharmacists.
c. Reducing the burden of HIPAA privacy requirements
d. Allowing pharmacists to bill their services at a higher level of complexity. - answera.
Facilitating development of supporting infrastructure, such as electronic health records
(EHR).
2. Which of the following activities is generally associated with the "collect" step of the
Pharmacist's Patient Care Process?
a. Compiling a list of the patient's medications.
b. Assessing a patient's adherence to prescribed medications.
c. Educating the patient about the use of medications.
d. Contacting a prescriber with concerns about medications - answera. Compiling a list
of the patient's medications.
3. Which of the following activities is generally associated with the "implement" step of
the Pharmacist's Patient Care Process?
a. Provide education and self-management training to the patient or caregiver.
b. Assess immunization status and the need for preventive care and other health care
services, where appropriate.
c. Evaluate relevant health data that may include medical history, health and wellness
information, biometric test results, and physical assessment findings.
d. Review each medication for appropriateness, effectiveness, safety, and patient
adherence. - answera. Provide education and self-management training to the patient or
caregiver.
4. According to the consensus document Medication Therapy Management Services
Definition and Program Criteria, which of the following activities would be considered a
part of MTM services?
a. Answering a patient's question when he or she picks up a prescription.
b. Performing chart reviews for a long-term care facility.
c. Performing a comprehensive medication review for a patient to identify, resolve, and
prevent medication-related problems.
d. Providing recommendations to a formulary committee. - answerc. Performing a
comprehensive medication review for a patient to identify, resolve, and prevent
medication-related problems.
5. Which of the following is an important distinction between MTM services and disease
management programs?
, a. Diet and exercise are never addressed during MTM services.
b. Disease management programs focus on a specific disease rather than the patient's
overall health concerns.
c. Disease management programs generally are not documented.
d. Only MTM services include clinical assessment such as taking a patient's blood
pressure. - answerb. Disease management programs focus on a specific disease rather
than the patient's overall health concerns
6. Which of the following statements about the core elements model framework for MTM
services is true?
a. The model applies only to community pharmacy practice.
b. The model can be used only for MTM services that are delivered to patients with
Medicare Part D coverage.
c. The model defines a minimum level of service required for services to be considered
MTM.
d. The model is designed to improve the efficiency of MTM services while helping to
address medication-related problems. - answerd. The model is designed to improve the
efficiency of MTM services while helping to address medication-related problems.
7. Which of the following statements about a personal medication record (PMR) is true?
a. The PMR never needs to be updated.
b. The patient should keep the PMR private and not share it with other health care
providers.
c. The PMR should include only prescription medications.
d. The PMR is designed as a tool to help patients self-manage their medications. -
answerd. The PMR is designed as a tool to help patients self-manage their medications.
8. The primary purpose of the patient's medication-related action (MAP) plan is to:
a. Help the pharmacist create a list of therapy goals for the patient.
b. Provide the patient with a list of actions that he or she should perform to optimize
medication use.
c. Be a communication tool for collaborating with other health care providers.
d. Act as a tool to report medication changes to third-party payers. - answerb. Provide
the patient with a list of actions that he or she should perform to optimize medication
use.
9. When a pharmacist identifies a medication-related problem during the medication
therapy review, which of the following actions would be an inappropriate intervention?
a. Collaborating with other health care professionals.
b. Providing services outside the scope of pharmacy practice without a physician's
approval.
c. Providing additional care within the scope of pharmacy practice based on the
pharmacist's level of expertise.
d. Referring the patient to another health care provider. - answerb. Providing services
outside the scope of pharmacy practice without a physician's approval.
1. Which of the following is a benefit of standardizing the patient care process?
a. Facilitating development of supporting infrastructure, such as electronic health
records (EHR).
b. Minimizing the amount of clinical training required for pharmacists.
c. Reducing the burden of HIPAA privacy requirements
d. Allowing pharmacists to bill their services at a higher level of complexity. - answera.
Facilitating development of supporting infrastructure, such as electronic health records
(EHR).
2. Which of the following activities is generally associated with the "collect" step of the
Pharmacist's Patient Care Process?
a. Compiling a list of the patient's medications.
b. Assessing a patient's adherence to prescribed medications.
c. Educating the patient about the use of medications.
d. Contacting a prescriber with concerns about medications - answera. Compiling a list
of the patient's medications.
3. Which of the following activities is generally associated with the "implement" step of
the Pharmacist's Patient Care Process?
a. Provide education and self-management training to the patient or caregiver.
b. Assess immunization status and the need for preventive care and other health care
services, where appropriate.
c. Evaluate relevant health data that may include medical history, health and wellness
information, biometric test results, and physical assessment findings.
d. Review each medication for appropriateness, effectiveness, safety, and patient
adherence. - answera. Provide education and self-management training to the patient or
caregiver.
4. According to the consensus document Medication Therapy Management Services
Definition and Program Criteria, which of the following activities would be considered a
part of MTM services?
a. Answering a patient's question when he or she picks up a prescription.
b. Performing chart reviews for a long-term care facility.
c. Performing a comprehensive medication review for a patient to identify, resolve, and
prevent medication-related problems.
d. Providing recommendations to a formulary committee. - answerc. Performing a
comprehensive medication review for a patient to identify, resolve, and prevent
medication-related problems.
5. Which of the following is an important distinction between MTM services and disease
management programs?
, a. Diet and exercise are never addressed during MTM services.
b. Disease management programs focus on a specific disease rather than the patient's
overall health concerns.
c. Disease management programs generally are not documented.
d. Only MTM services include clinical assessment such as taking a patient's blood
pressure. - answerb. Disease management programs focus on a specific disease rather
than the patient's overall health concerns
6. Which of the following statements about the core elements model framework for MTM
services is true?
a. The model applies only to community pharmacy practice.
b. The model can be used only for MTM services that are delivered to patients with
Medicare Part D coverage.
c. The model defines a minimum level of service required for services to be considered
MTM.
d. The model is designed to improve the efficiency of MTM services while helping to
address medication-related problems. - answerd. The model is designed to improve the
efficiency of MTM services while helping to address medication-related problems.
7. Which of the following statements about a personal medication record (PMR) is true?
a. The PMR never needs to be updated.
b. The patient should keep the PMR private and not share it with other health care
providers.
c. The PMR should include only prescription medications.
d. The PMR is designed as a tool to help patients self-manage their medications. -
answerd. The PMR is designed as a tool to help patients self-manage their medications.
8. The primary purpose of the patient's medication-related action (MAP) plan is to:
a. Help the pharmacist create a list of therapy goals for the patient.
b. Provide the patient with a list of actions that he or she should perform to optimize
medication use.
c. Be a communication tool for collaborating with other health care providers.
d. Act as a tool to report medication changes to third-party payers. - answerb. Provide
the patient with a list of actions that he or she should perform to optimize medication
use.
9. When a pharmacist identifies a medication-related problem during the medication
therapy review, which of the following actions would be an inappropriate intervention?
a. Collaborating with other health care professionals.
b. Providing services outside the scope of pharmacy practice without a physician's
approval.
c. Providing additional care within the scope of pharmacy practice based on the
pharmacist's level of expertise.
d. Referring the patient to another health care provider. - answerb. Providing services
outside the scope of pharmacy practice without a physician's approval.
